Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer -- Barrons.com

Barron's11:58 ET

Bernstein Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Raises Target Price to $310

Moomoo NewsJan 7 12:32 ET · Ratings

Alnylam Pharmaceuticals Is Maintained at Outperform by Bernstein

Dow JonesJan 7 12:29 ET · Ratings

Alnylam Pharmaceuticals Analyst Ratings

BenzingaJan 7 12:16 ET · Ratings

Express News | Alnylam Pharmaceuticals Inc : Bernstein Cuts Target Price to $310 From $314

ReutersJan 7 03:39 ET

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic

BenzingaJan 3 13:08 ET